GLYPHCBD
LIVE

Serial Number

99518265

Owner

Seaport Therapeutics, Inc.

Attorney

Nicholas B. Hawkins

Filing Date

Nov 26, 2025

Add to watchlist:

No watchlists yet
View on USPTO

GLYPHCBD Trademark

Serial Number: 99518265

GLYPHCBD is a trademark filed by Seaport Therapeutics, Inc. on November 26, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Seaport Therapeutics, Inc. (13 trademarks)

6 Tide St.
Boston, MA 02210

Entity Type: 03

Trademark Details

Filing Date

November 26, 2025

Registration Date

Not Registered

Published for Opposition

January 27, 2026

Goods & Services

Research and development in the pharmaceutical and biotechnology fields; medical and scientific research in the field of clinical trials

Technologies in the nature of pharmaceutical preparations of drugs that facilitate the delivery of pharmaceutical compounds for oral administration of therapeutics utilizing the lymphatic system to treat human and animal disease and illness, namely infectious diseases, inflammatory disorders, respiratory diseases, cardiovascular diseases, autoimmune disorders, gastrointestinal disorders, cancer, hematological diseases, neurological diseases, neuropsychiatric disorders, hepatic diseases, renal diseases, lymphatic disorders, metabolic disorders, genetic disorders, dermatological disorders, ocular diseases, and orphan diseases

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 24, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 27, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 27, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 21, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 2, 2026 CNSA
ASSIGNED TO EXAMINER
Dec 30, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 26, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 26, 2025 NWOS
NEW APPLICATION ENTERED
Nov 26, 2025 NWAP